Clinical Trials Directory

Trials / Completed

CompletedNCT06647056

Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Psychogenic non-epileptic seizures (PNES) are functional paroxysmal motor disorders that may be clinically suggestive of epilepsy but are not associated with the electroencephysiological and electroencephalographic changes of epilepsy. Thus, hyper-connectivity of the regions of the default mode network (DMN) linked to executive control could be involved in the impairment of cognitive control capacities in patients suffering from PNES. Also, the HYCORE study (NCT02329626), showed that dysregulation of frontal regions involved in attentional and emotional regulation is correlated with motor symptoms in patients with functional neurological disorders. The researchers of this study hypothesized that psilocybin would improve cognitive control in patients with PNES.

Conditions

Interventions

TypeNameDescription
DRUGPsilocybinAdministration of psilocybin 25 mg
OTHERMRITwo standard MRI + fMRI scans before (D-3) and after (D5) treatment

Timeline

Start date
2024-12-19
Primary completion
2025-01-03
Completion
2025-05-22
First posted
2024-10-17
Last updated
2025-08-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06647056. Inclusion in this directory is not an endorsement.